Added to YB: 2024-05-24
Pitch date: 2024-04-20
CERT [bullish]
Certara, Inc.
-67.81%
current return
Author Info
No bio for this author
Company Info
Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the Americas, Europe, the Middle East, Africa, and Asia Pacific.
Market Cap
$745.2M
Pitch Price
$16.06
Price Target
N/A
Dividend
N/A
EV/EBITDA
9.00
P/E
-48.05
EV/Sales
2.14
Sector
Health Care Technology
Category
growth
The London Company Small Cap Strategy New Portfolio Holding: Certara, Inc.
CERT: Biosim leader w/ 50%+ rev from 39/40 top biopharmas. High-margin recurring revs, Simcyp the gold std. Mid-teens% biosim mkt growth tailwind. Strong b/s & cash flow gen. Low disruption risk.
Read full article (1 min)